Skip to main contentSkip to navigation
Sirius Investors

TEVJF Stock: Teva Pharmaceutical Industries Limited Stock Price, Analysis & Insights

Get live TEVJF stock price $30.34, comprehensive Teva Pharmaceutical Industries Limited stock analysis, charts, news, and expert forecast. Real-time TEVJF stock data and investment insights.

30.34
0.00%Today
TEVJFTeva Pharmaceutical Industries Limited • Other OTC • Healthcare
Market Cap
35.33B
Volume
100
52W High
37.00
52W Low
14.00

Loading chart data...

Teva Pharmaceutical Industries Limited (TEVJF) Overview

Teva Pharmaceutical Industries Limited (TEVJF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, TEVJF trades at $30.34 with a market capitalization of 35.33B . Over the past 52 weeks, TEVJF has traded between $14.00 and $37.00 , with the current price positioned at approximately ...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 35.33B
  • Current price: $30.34
  • 52-week range: $14.00 - $37.00
  • P/E ratio: 22.64

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Teva Pharmaceutical Industries Limited operates as a global pharmaceutical enterprise, engaging in the research, production, marketing, and distribution of generic medications, specialized pharmaceutical products, and biopharmaceuticals. The company'...

Company Information

CEO
Richard D. Francis
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
37000

Contact Information

Address
124 Dvora Hanevi’a Street
Country
IL

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 22.6)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Teva Pharmaceutical Industries Limited shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Teva Pharmaceutical Industries Limited
  • Investors should consider how Teva Pharmaceutical Industries Limited fits within their overall portfolio allocation

Market Cap

35.33B

P/E Ratio (TTM)

22.64

Beta

0.85

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.